**Core Concept**
Nitric oxide (NO) and prostacyclin (PGI2) are potent vasodilators that play crucial roles in regulating vascular tone. They exert their effects by stimulating the production of cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP), respectively, leading to smooth muscle relaxation and vasodilation.

**Why the Correct Answer is Right**
Prostacyclin (PGI2) is synthesized from arachidonic acid by the enzyme cyclooxygenase (COX) in endothelial cells. It binds to its receptor on the surface of vascular smooth muscle cells, activating adenylate cyclase and increasing intracellular cAMP levels. This leads to the activation of protein kinase A (PKA), which phosphorylates and relaxes the smooth muscle cells, resulting in vasodilation. Prostacyclin is particularly potent in promoting vasodilation and inhibiting platelet aggregation.

**Why Each Wrong Option is Incorrect**
**Option A:** Nitric oxide (NO) is also a potent vasodilator, but it is not the most potent among the options listed. While NO is a key regulator of vascular tone, prostacyclin has a more pronounced effect on vasodilation.
**Option B:** Endothelin-1 (ET-1) is a potent vasoconstrictor, not a vasodilator. It binds to its receptor on the surface of vascular smooth muscle cells, activating phospholipase C and increasing intracellular calcium levels, leading to vasoconstriction.
**Option C:** Histamine is a vasodilator, but its effect is more pronounced in the context of allergic reactions and inflammation. It acts on H1 and H2 receptors, leading to increased vascular permeability and vasodilation.

**Clinical Pearl / High-Yield Fact**
Prostacyclin is a key regulator of vascular tone, particularly in the pulmonary circulation. Its deficiency has been implicated in pulmonary hypertension, a condition characterized by elevated pulmonary artery pressure and resistance.

**Correct Answer:** C. Prostacyclin (PGI2)